1. Chinese Pharmacopoeia committee. Pharmacopoeia of the People’s Republic of China [M]. Beijing: China Medical Science Press, 2010: 61. (in Chinese)
2. LIU Xiang-qian. Studies on the active constituents of Acanthopanax gracilistylus W.W. Smith [D]. Korea: Kyung Hee University, 2003: 9–11.
3. FAN Xue-gong, LIU Hong-bo, LIU Xiang-qian. The use of acankoreoside A and acankoreanogenin with anti-inflammation activity: China, ZL200710198460.x [P]. 2010, 02. (in Chinese)
4. ZOU Qin-peng. Studies on anti-HMGB1 activities of triterpenoids from leaves of two Acanthopanax Miq. Plants [D]. Changsha: Central South University College of Chemistry and Chemical Engineering. 2012: 34–38. (in Chinese)
5. ZHANG Bao-xin, LI Ning, ZHANG Zu-ping, LIU Hong-bo, ZHOU Rong-rong, ZHONG Bai-yun, ZOU Ming-xiang, DAI Xia-hong, XIAO Mei-fang, LIU Xiang-qian, FAN Xue-gong. Protective effect of Acanthopanax gracilistylus-extracted acankoreanogenin A on mice with fulminant hepatitis [J]. International Immunopharmacology, 2011, 10(8): 1018–1023